IFNA2 Protéine
-
- Antigène Voir toutes IFNA2 Protéines
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Type de proteíne
- Recombinant
- Activité biologique
- Active
-
Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Application
- Functional Studies (Func)
- Attributs du produit
- Recombinant Human IFNA2
- Pureté
- >95 % as determined by SDS-PAGE
- niveau d'endotoxine
- < 1.0 EU of endotoxin/μg of protein
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- A quick spin of the vial followed by reconstitution in sterile distilled water to a concentration not less than 0.1 mg/mL is recommended. Please note, filter sterilization is a must following reconstitution. This solution can then be diluted into other buffers.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- The lyophilized protein is stable for at least one year from date of receipt at -70°C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8°C for one month, or at -20°C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
-
- Antigène
- IFNA2 (Interferon, alpha 2 (IFNA2))
- Autre désignation
- IFNA2 (IFNA2 Produits)
- Synonymes
- IFN-alphaA Protein, IFNA Protein, IFNA2B Protein, INFA2 Protein, Ifa2 Protein, IFNA2 Protein, interferon alpha 2 Protein, interferon, alpha 2 Protein, interferon-alpha-2 Protein, interferon alpha-2 Protein, IFNA2 Protein, Ifna2 Protein, ifna2 Protein, IFN-ALPHA2 Protein, LOC102142148 Protein
- Poids moléculaire
- 19
- ID gène
- 3440
- UniProt
- P01563
- Pathways
- Signalistation JAK/STAT, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
-